Kaposi's varicelliform eruption (KVE) is a disseminated cutaneous infection usually induced by herpesvirus type 1 or 2, vaccinia virus or Coxsackie A16 virus in a patient with an underlying dermatosis. Risk factors for KVE reported in the literature include erythroderma, systemic sepsis, therapy with immunosuppressants such as methotrexate and systemic steroids, and therapy with systemic retinoids. The occurrence of KVE in psoriasis is rare and it predominantly appears in patients affected by erythrodermic psoriasis during immunosuppressive treatment. We report our experience of a remarkable case of a patient affected by severe erythrodermic psoriasis and KVE that healed after antiviral treatment and after having received secukinumab. After 1 year, psoriasis was cleared and no recurrence of KVE had occurred.
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption / Campanati, A.; Molinelli, E.; Brisigotti, V.; Brancorsini, D.; Bobyr, I.; Diotallevi, F.; Radi, G.; Offidani, A.. - In: CASE REPORTS IN DERMATOLOGY. - ISSN 1662-6567. - 11:Suppl 1(2019), pp. 4-10. [10.1159/000501992]
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption
Campanati A.;Molinelli E.;Brisigotti V.;Bobyr I.;Diotallevi F.;Radi G.;Offidani A.
2019-01-01
Abstract
Kaposi's varicelliform eruption (KVE) is a disseminated cutaneous infection usually induced by herpesvirus type 1 or 2, vaccinia virus or Coxsackie A16 virus in a patient with an underlying dermatosis. Risk factors for KVE reported in the literature include erythroderma, systemic sepsis, therapy with immunosuppressants such as methotrexate and systemic steroids, and therapy with systemic retinoids. The occurrence of KVE in psoriasis is rare and it predominantly appears in patients affected by erythrodermic psoriasis during immunosuppressive treatment. We report our experience of a remarkable case of a patient affected by severe erythrodermic psoriasis and KVE that healed after antiviral treatment and after having received secukinumab. After 1 year, psoriasis was cleared and no recurrence of KVE had occurred.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
